Take a look at some of Friday's midday movers:
(HNZ) moved lower despite accelerating its 51.5 cent quarterly dividend from January to December.
(LMT)rose after news it had reached agreement with the Pentagon to build new block of 32 F-35 Joint Strike fighters.
(ULTA) jumped after Wells Fargo upgraded the stock to "outperform" in the aftermath of the company's better-than-expected quarterly results and solid current-quarter outlook, saying it was impressed with its store opening plans.
(VRSN) was slammed after the website registry operator lost certain rights to increase prices under a new agreement with the Commerce Department.
(CBK) gained ground after the women's clothing retailer posted a quarterly profit.
(BF-B) fell after Goldman Sachs downgraded the stock to "sell" from "neutral," based in valuation.
(ACTV) rose after Bank of America/Merrill Lynch upgraded the stock to "buy" from "underperform."
(CLWR) moved higher amid renewed speculation Sprint will buy the company.
(EXEL) moved lower after receiving approval from the FDA for its cancer drug Cometriq that only covers a rare form of thyroid cancer. JPMorgan said the number of eligible patients is less than half of what was previously thought.
(GCO) slid after the retailer's CEO said November sales dipped in November, partly because of Superstorm Sandy.
(Read More: See CNBC's Market Insider Blog)
-By CNBC's Rich Fisherman.
Questions? Comments? Email us at firstname.lastname@example.org
More From CNBC